The Institut Pasteur de Lille
The Institut Pasteur de Lille was created in 1894 to respond to public health concerns at the end of the 19th century, which included the fight against infectious diseases, through the research work on pathogens, the development of vaccines and serum and the promotion of preventive and hygienic measures.
From the very beginning, the Institut Pasteur de Lille has organised its actions around the following three objectives : high-level fundamental research, disease prevention and the development of healthcare standards with regards to the general public. This complies with the core values of Institut Pasteur de Lille.
Positioning and structuring of the project
To understand the significant changes in health needs, and fully exploit the rapid development of scientific methods, Institut Pasteur de Lille has decided to organise its activities within an interdisciplinary and multi-sector campus, whose central focus is to understand the primary pathophysiological mechanisms of the diseases of greatest impact, in order to design and develop diversified health products for sustainable healthcare : treatments, diagnostic assessments, vaccines and innovative disease prevention protocols.
Furthermore, the Institut Pasteur de Lille has set itself two priorities :
- Infectious diseases, in the context of emerging epidemic risks and antibiotic resistance, through the innovative INTHREPIDE programme. The objective of this programme : to identify new therapies for emerging viral infections and infections by multi-resistant bacteria by bringing together a critical mass of scientists combining in a complementary and synergistic manner all the necessary expertise.
- Degenerative diseases related to lifestyle, aging, and changes in the environment (diabetes and its complications, cardiovascular and respiratory diseases, neurodegenerative diseases, senescence, fibrosis and cancer).
The strategy of Institut Pasteur de Lille can be broken down into 4 interdependant operational objectives
A search for excellence
Outlining an interdisciplinary research platform in pursuit of excellence with a holistic approach to the organisation, by encouraging collaborations between academic disciplines and research units, with the aim of identifying the earliest stages of the pathophysiological mechanisms of diseases, during which curative or preventive action would potentially be more effective. Maintaining the highest level of scientific investigation thanks to the most recent innovations in observation and analysis will be sought.
An inter-sector ecosystem
Developing an inter-sector ecosystem by bringing together academic and industrial laboratories to facilitate the transformation of scientific results into innovative healthcare products (drugs, diagnostic assessments and vaccines, disease prevention proto- cols).
Conducting assessed healthcare measures, with a progressive deployment from the Hauts-de-France region to all of France. These actions will be implemented by building links between research on the mechanisms of resilience and resistance to stressors on the one hand, and disease prevention on the other. These links naturally go both ways : from fundamental research (including human and social sciences) to disease prevention actions evaluated at the population level on the one hand, to observation of the population according to mechanistic hypotheses on the other. The experience of Institut Pasteur de Lille in these areas is unique in France, and has no equivalent in the academic or hospital infrastructures.
A “evidence-based” knowledge
Passing on “evidence-based” knowledge by participating in a “life-long” offer of training, internally (career development) as well as in partnership with the University of Lille and the I-site (ULNE) and the international network of Institut Pasteur, and by communicating directly to the public through conferences, and by exploiting all available means and technologies, to facilitate personalised communication for individual coaching in particular.